Skip to main content

Table 1 Proposed participating sites

From: Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial

Department of Anesthesiology and Intensive Care Medicine, Charité-Universitätsmedizin Berlin

Department of Intensive Care, University Medical Center Hamburg-Eppendorf, Hamburg

Department of Anesthesiology, University Hospital Ulm, Ulm

Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital; Jena

Department of Anesthesiology, Special Pain Management and Intensive Care Medicine, General Hospital of Heidenheim, Heidenheim

Department of Anaesthesiology and Intensive Care Medicine, University Hospital of Cologne, Cologne

Department III of Internal Medicine, University Hospital of Cologne, Cologne

Department of Anesthesiology, Heidelberg University Hospital, Heidelberg

Department of Anesthesiology, Intensive Care, Transfusion and Emergency Medicine and Pain Therapy, Bethel Hospital Bielefeld, Bielefeld

Department of Anesthesiology and Intensive Care Medicine, Hospital of Sindelfingen, Sindelfingen

Department of Internal Medicine I, Intensive Care Unit, University Hospital of Würzburg, Würzburg

Back to article page

Trials

ISSN: 1745-6215